Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi

Clinical trial NCT05929222 · RECRUITING

Trial details

NCT number: NCT05929222
Sponsor: Fondazione Italiana Linfomi - ETS
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Follicular Lymphoma

Start date: 2023-12-14
Primary completion: 2031-04-01
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.